GWMT (GW Medical Technologies) targets 2006 launch for Alzheimer's diagnostic
This article was originally published in Clinica
Executive Summary
GW Medical Technologies (GWMT) has joined the race to bring to market the first diagnostic for Alzheimer's disease. The Phoenix, Arizona firm said that it expects to launch its LymPro blood test in the US by early 2006.